These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 30499183)

  • 1. p62/SQSTM1: 'Jack of all trades' in health and cancer.
    Sánchez-Martín P; Saito T; Komatsu M
    FEBS J; 2019 Jan; 286(1):8-23. PubMed ID: 30499183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system.
    Sánchez-Martín P; Sou YS; Kageyama S; Koike M; Waguri S; Komatsu M
    EMBO Rep; 2020 Mar; 21(3):e48902. PubMed ID: 31916398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.
    Katsuragi Y; Ichimura Y; Komatsu M
    FEBS J; 2015 Dec; 282(24):4672-8. PubMed ID: 26432171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62.
    Foster A; Scott D; Layfield R; Rea SL
    Mol Cell Neurosci; 2019 Jul; 98():32-45. PubMed ID: 30954537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p62 at the interface of autophagy, oxidative stress signaling, and cancer.
    Nezis IP; Stenmark H
    Antioxid Redox Signal; 2012 Sep; 17(5):786-93. PubMed ID: 22074114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/SQSTM1 - steering the cell through health and disease.
    Sánchez-Martín P; Komatsu M
    J Cell Sci; 2018 Nov; 131(21):. PubMed ID: 30397181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
    Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
    Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death.
    Park JS; Oh SY; Lee DH; Lee YS; Sung SH; Ji HW; Lee MJ; Lee YH; Rhee SG; Bae SH
    Free Radic Res; 2016 Dec; 50(12):1408-1421. PubMed ID: 27780373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W; Wang Z; Fu Z; Ma H; Jiang M; Xu A; Zhang W
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1.
    Hashimoto K; Simmons AN; Kajino-Sakamoto R; Tsuji Y; Ninomiya-Tsuji J
    Antioxid Redox Signal; 2016 Dec; 25(17):953-964. PubMed ID: 27245349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.
    Riz I; Hawley TS; Marsal JW; Hawley RG
    Oncotarget; 2016 Oct; 7(41):66360-66385. PubMed ID: 27626179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.
    Taniguchi K; Yamachika S; He F; Karin M
    FEBS Lett; 2016 Aug; 590(15):2375-97. PubMed ID: 27404485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response.
    Yang Y; Willis TL; Button RW; Strang CJ; Fu Y; Wen X; Grayson PRC; Evans T; Sipthorpe RJ; Roberts SL; Hu B; Zhang J; Lu B; Luo S
    Nat Commun; 2019 Aug; 10(1):3759. PubMed ID: 31434890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNOT2 promotes degradation of p62/SQSTM1 as a negative regulator in ATG5 dependent autophagy.
    Jeong K; Kwon HY; Jeong MS; Sohn EJ; Kim SH
    Oncotarget; 2017 Jul; 8(28):46034-46046. PubMed ID: 28537904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.
    Mildenberger J; Johansson I; Sergin I; Kjøbli E; Damås JK; Razani B; Flo TH; Bjørkøy G
    Autophagy; 2017 Oct; 13(10):1664-1678. PubMed ID: 28820283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p62 as a therapeutic target for tumor.
    Tao M; Liu T; You Q; Jiang Z
    Eur J Med Chem; 2020 May; 193():112231. PubMed ID: 32193054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p62: Friend or Foe? Evidences for
    Emanuele S; Lauricella M; D'Anneo A; Carlisi D; De Blasio A; Di Liberto D; Giuliano M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p62/SQSTM1/A170: physiology and pathology.
    Komatsu M; Kageyama S; Ichimura Y
    Pharmacol Res; 2012 Dec; 66(6):457-62. PubMed ID: 22841931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function.
    Sultana MA; Cluning C; Kwong WS; Polain N; Pavlos NJ; Ratajczak T; Walsh JP; Xu J; Rea SL
    PLoS One; 2021; 16(11):e0259556. PubMed ID: 34735553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of p62-keap1-Nrf2 antioxidant pathway in the early stage of acetaminophen-induced acute liver injury in mice.
    Shen Z; Wang Y; Su Z; Kou R; Xie K; Song F
    Chem Biol Interact; 2018 Feb; 282():22-28. PubMed ID: 29331651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.